Ordinary Rebalance | Solactive BBVA Health & Wellness SIC MXN Index | Effective Date 14th June 2023
In the ordinary rebalance, the following index composition will be implemented effective open 14.06.2023:
ABBOTT LABORATORIES |
ALCON INC |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
ALIGN TECHNOLOGY INC |
APPLE INC |
ASAHI INTECC CO LTD |
ASTRAZENECA PLC |
BECTON DICKINSON AND CO |
BIOMARIN PHARMACEUTICAL INC |
BIONTECH SE |
CENTENE CORP |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
COOPER COMPANIES INC |
CSL LTD ORD |
CVS HEALTH CORP |
DEMANT A/S |
DEXCOM INC |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
ESTEE LAUDER COMPANIES INC |
FRESENIUS SE & CO KGAA |
GENMAB A/S |
GILEAD SCIENCES INC |
GSK PLC |
HUMANA INC |
ILLUMINA INC |
INCYTE CORP |
INTUITIVE SURGICAL INC |
IQVIA HOLDINGS INC |
JOHNSON & JOHNSON |
L OREAL SA |
LONZA GROUP AG |
MERCK & CO. INC. |
MODERNA INC |
NOVO NORDISK A/S |
PFIZER INC |
REGENERON PHARMACEUTICALS |
ROYALTY PHARMA PLC- CL A |
SANTEN PHARMACEUTICAL CO LTD ORD |
SARTORIUS STEDIM BIOTECH SA |
SEAGEN INC |
SIEMENS AG |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
UNITEDHEALTH GROUP INC |
VEEVA SYSTEMS INC |
VERTEX PHARMACEUTICALS INC |
WEST PHARMACEUTICAL SERVICES INC |
ZIMMER BIOMET HOLDINGS INC |